Nifty
Sensex
:
:
10389.70
33679.24
40.95 (0.40%)
91.16 (0.27%)

Pharmaceuticals & Drugs

Rating :
63/99

BSE: 500302 | NSE: PEL

2661.95
70.85 (2.73%)
24-Nov-2017 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 2612.00
  • 2668.00
  • 2583.35
  • 2591.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 131750
  • 3507.12
  • 3088.95
  • 1445.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 44,656.74
  • 31.86
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 73,566.82
  • 0.81%
  • 2.99

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.41%
  • 1.54%
  • 11.78%
  • FII
  • DII
  • Others
  • 2.64%
  • 1.26%
  • 31.37%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 17
Sep 16
Var%
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Net Sales
2,535.86
1,966.15
28.98%
2,254.07
1,776.22
26.90%
2,462.64
1,733.51
42.06%
2,341.74
1,858.68
25.99%
Expenses
1,265.97
1,222.50
3.56%
1,192.26
1,138.07
4.76%
1,430.29
1,265.87
12.99%
1,256.75
1,230.47
2.14%
EBITDA
1,269.89
743.65
70.76%
1,061.81
638.15
66.39%
1,032.35
467.64
120.76%
1,084.99
628.21
72.71%
EBIDTM
50.08%
37.82%
47.11%
35.93%
41.92%
26.98%
46.33%
33.80%
Other Income
75.39
42.34
78.06%
83.84
53.01
58.16%
86.32
39.18
120.32%
52.08
31.03
67.84%
Interest
724.71
455.23
59.20%
673.23
395.40
70.27%
589.72
303.88
94.06%
590.63
250.21
136.05%
Depreciation
129.33
73.28
76.49%
122.91
76.77
60.10%
121.54
90.05
34.97%
110.11
87.26
26.19%
PBT
491.24
257.48
90.79%
349.51
218.99
59.60%
399.27
185.25
115.53%
434.52
306.75
41.65%
Tax
189.75
3.12
5,981.73%
102.05
46.06
121.56%
103.18
37.60
174.41%
75.76
24.87
204.62%
PAT
301.49
254.36
18.53%
247.46
172.93
43.10%
296.09
147.65
100.54%
358.76
281.88
27.27%
PATM
11.89%
12.94%
10.98%
9.74%
12.02%
8.52%
15.32%
15.17%
EPS
22.25
17.75
25.35%
17.54
13.38
31.09%
18.02
10.45
72.44%
23.42
18.64
25.64%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
8,503.65
6,341.51
5,122.61
4,502.74
3,520.19
2,158.87
1,673.08
3,624.47
3,244.81
2,848.28
Net Sales Growth
34.10%
23.79%
13.77%
27.91%
63.06%
29.04%
-53.84%
11.70%
13.92%
 
Cost Of Goods Sold
1,401.10
1,305.94
1,314.40
1,195.02
1,113.57
927.24
694.03
1,397.21
1,236.54
1,092.96
Gross Profit
7,102.55
5,035.57
3,808.21
3,307.72
2,406.62
1,231.63
979.05
2,227.26
2,008.27
1,755.32
GP Margin
83.52%
79.41%
74.34%
73.46%
68.37%
57.05%
58.52%
61.45%
61.89%
61.63%
Total Expenditure
4,990.04
4,649.26
4,237.46
3,867.83
3,105.38
2,159.80
2,465.72
2,944.25
2,699.75
2,331.15
Power & Fuel Cost
101.03
98.73
92.15
89.35
82.12
65.82
59.82
79.26
81.07
78.74
% Of Sales
1.19%
1.56%
1.80%
1.98%
2.33%
3.05%
3.58%
2.19%
2.50%
2.76%
Employee Cost
1,793.87
1,683.05
1,294.76
1,136.95
796.53
436.42
411.65
573.32
488.37
461.93
% Of Sales
21.10%
26.54%
25.28%
25.25%
22.63%
20.22%
24.60%
15.82%
15.05%
16.22%
Manufacturing Exp.
506.60
514.80
583.17
557.39
520.26
317.34
145.94
186.33
210.20
205.99
% Of Sales
5.96%
8.12%
11.38%
12.38%
14.78%
14.70%
8.72%
5.14%
6.48%
7.23%
General & Admin Exp.
628.30
567.54
524.38
473.46
306.39
201.10
202.80
300.12
274.64
216.95
% Of Sales
7.39%
8.95%
10.24%
10.51%
8.70%
9.32%
12.12%
8.28%
8.46%
7.62%
Selling & Distn. Exp.
266.17
205.77
269.81
245.82
194.24
121.27
110.50
250.27
202.98
146.95
% Of Sales
3.13%
3.24%
5.27%
5.46%
5.52%
5.62%
6.60%
6.91%
6.26%
5.16%
Miscellaneous Exp.
292.97
273.43
158.79
169.84
92.27
90.61
840.98
157.74
205.95
146.95
% Of Sales
3.45%
4.31%
3.10%
3.77%
2.62%
4.20%
50.27%
4.35%
6.35%
4.48%
EBITDA
3,513.61
1,692.25
885.15
634.91
414.81
-0.93
-792.64
680.22
545.06
517.13
EBITDA Margin
41.32%
26.69%
17.28%
14.10%
11.78%
-0.04%
-47.38%
18.77%
16.80%
18.16%
Other Income
233.75
251.66
254.52
225.43
196.17
472.23
1,317.52
152.92
158.27
70.93
Interest
2,045.45
974.08
510.60
1,049.58
575.01
215.46
88.83
183.81
198.40
86.61
Depreciation
381.70
255.45
289.87
246.90
209.56
129.29
95.86
142.65
119.57
94.73
PBT
1,320.21
714.38
339.20
-436.14
-173.59
126.55
340.19
506.68
385.36
406.72
Tax
228.12
49.51
344.96
62.75
24.76
5.63
3,679.71
18.03
21.94
37.66
Tax Rate
17.41%
6.51%
11.36%
-14.43%
-12.85%
4.66%
22.22%
3.61%
6.44%
10.10%
PAT
1,082.43
710.53
2,690.68
-498.28
-223.06
111.50
12,883.36
481.90
316.25
333.78
PAT before Minority Interest
1,082.14
710.53
2,690.39
-497.52
-217.48
115.26
12,883.67
481.74
318.81
335.13
Minority Interest
0.29
0.00
0.29
-0.76
-5.58
-3.76
-0.31
0.16
-2.56
-1.35
PAT Margin
12.73%
11.20%
52.53%
-11.07%
-6.34%
5.16%
770.04%
13.30%
9.75%
11.72%
PAT Growth
52.34%
-73.59%
639.99%
-123.38%
-300.05%
-99.13%
2573.45%
52.38%
-5.25%
 
Unadjusted EPS
72.57
52.43
165.20
-29.10
-13.20
6.60
572.20
21.00
15.10
15.90

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
14,882.57
12,948.35
11,735.93
9,321.06
10,723.56
11,242.03
11,836.42
1,684.89
1,317.07
1,092.59
Share Capital
34.51
34.51
34.51
34.51
34.51
34.51
33.58
41.80
41.80
41.80
Total Reserves
14,848.06
12,913.84
11,701.42
9,286.55
10,689.05
11,207.52
11,802.84
1,643.09
1,275.27
1,050.79
Non-Current Liabilities
18,775.97
11,759.51
7,817.04
6,709.95
1,598.43
1,180.37
1,155.32
1,351.74
1,411.63
806.00
Secured Loans
11,714.16
3,099.39
1,539.08
504.42
609.44
208.81
232.25
575.36
451.66
346.90
Unsecured Loans
2,781.53
4,374.61
2,248.40
2,175.18
551.60
439.41
424.30
719.60
887.42
369.43
Long Term Provisions
4,689.03
4,497.72
4,048.77
4,026.55
346.63
346.81
258.89
0.00
0.00
0.00
Current Liabilities
18,962.28
10,542.27
5,694.05
9,490.09
11,764.78
6,111.55
4,693.23
1,041.96
1,070.46
771.80
Trade Payables
764.29
702.56
509.57
485.11
539.18
412.97
339.97
442.50
423.67
358.50
Other Current Liabilities
5,563.12
2,706.14
1,400.84
1,369.74
1,223.68
764.05
407.35
116.61
207.00
109.07
Short Term Borrowings
12,079.48
6,828.93
2,829.32
6,400.74
6,018.77
1,014.45
69.32
0.00
0.00
0.00
Short Term Provisions
555.39
304.64
954.32
1,234.50
3,983.15
3,920.08
3,876.59
482.85
439.79
304.23
Total Liabilities
52,634.03
35,250.25
25,276.13
25,521.10
24,098.57
18,544.29
17,690.73
4,078.59
3,806.61
2,675.25
Net Block
9,972.70
7,525.28
7,065.23
6,191.00
5,709.41
1,827.78
1,443.72
1,977.35
1,946.44
1,200.45
Gross Block
10,552.42
7,779.80
8,876.19
7,671.41
6,889.36
2,489.08
1,903.21
2,753.68
2,605.90
1,698.74
Accumulated Depreciation
579.72
254.52
1,810.96
1,480.41
1,179.95
661.30
459.49
776.33
659.46
498.29
Non Current Assets
43,470.62
30,595.31
19,911.89
21,149.44
16,397.63
13,307.38
8,036.06
2,145.56
2,066.92
1,323.79
Capital Work in Progress
879.63
355.02
277.14
491.07
371.96
260.77
138.45
135.66
92.65
58.09
Non Current Investment
21,716.66
15,682.30
6,820.88
9,249.93
6,969.82
6,577.86
380.86
32.55
27.83
65.25
Long Term Loans & Adv.
10,865.75
6,937.04
5,469.79
5,000.80
1,109.37
441.64
269.44
0.00
0.00
0.00
Other Non Current Assets
35.88
95.67
278.85
216.64
2,237.07
4,199.33
5,803.59
0.00
0.00
0.00
Current Assets
9,163.41
4,654.94
5,364.24
4,371.66
7,700.94
5,236.91
9,654.67
1,933.03
1,739.69
1,351.46
Current Investments
3,463.95
634.40
947.01
195.85
906.94
386.22
1,100.72
0.00
0.00
0.00
Inventories
723.07
723.77
674.94
652.30
541.82
465.60
382.56
469.45
483.36
403.20
Sundry Debtors
1,107.74
970.81
831.73
719.77
597.57
436.65
374.74
437.61
486.63
445.72
Cash & Bank
1,540.90
365.94
460.08
333.60
287.52
57.82
1,770.26
41.18
94.55
55.10
Other Current Assets
2,327.75
155.37
75.63
833.71
5,367.09
3,890.62
6,026.39
984.79
675.15
447.44
Short Term Loans & Adv.
2,097.06
1,804.65
2,374.85
1,636.43
4,048.46
3,785.30
4,114.27
976.93
665.13
405.08
Net Current Assets
-9,798.87
-5,887.33
-329.81
-5,118.43
-4,063.84
-874.64
4,961.44
891.07
669.23
579.66
Total Assets
52,634.03
35,250.25
25,276.13
25,521.10
24,098.57
18,544.29
17,690.73
4,078.59
3,806.61
2,675.25

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
-10,039.29
-6,956.19
-2,206.85
-1,604.43
-1,570.46
-684.78
-4,537.14
432.92
372.77
335.90
PBT
1,320.21
714.38
339.20
-436.14
-173.59
120.89
16,414.55
499.77
340.75
372.79
Adjustment
822.55
679.55
342.03
1,092.38
632.39
-140.32
-16,451.69
279.28
248.30
193.71
Changes in Working Capital
-11,716.05
-7,977.81
-2,495.18
-2,132.96
-1,880.13
-585.24
-314.67
-231.56
-85.31
-147.44
Cash after chg. in Working capital
-9,573.29
-6,583.88
-1,813.95
-1,476.72
-1,421.33
-604.67
-351.81
547.49
503.74
419.06
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-456.05
-329.63
-344.27
-125.70
-130.00
-74.45
-3,540.60
-107.66
-86.36
-49.23
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-9.95
-42.68
-48.63
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,420.20
-604.04
6,177.07
1,482.91
-1,664.46
-1,581.80
9,157.64
-157.46
-377.12
-280.94
Net Fixed Assets
-713.28
387.94
4.99
-74.35
-89.52
-357.29
614.10
-146.67
-289.09
13.48
Net Investments
779.61
-7,831.14
1,363.48
-1,963.06
-2,512.81
-5,527.04
-1,390.60
-62.67
-1.72
-1.76
Others
-2,486.53
6,839.16
4,808.60
3,520.32
937.87
4,302.53
9,934.14
51.88
-86.31
-292.66
Cash from Financing Activity
13,570.46
7,543.90
-3,864.63
125.84
3,280.68
640.17
-2,984.62
-313.57
-9.75
-55.98
Net Cash Inflow / Outflow
1,110.97
-16.33
105.59
4.32
45.76
-1,626.41
1,635.88
-38.11
-14.10
-1.02
Opening Cash & Equivalents
226.57
233.35
325.18
268.65
52.98
1,678.88
38.12
94.55
55.10
50.59
Closing Cash & Equivalent
1,364.21
226.57
447.01
325.18
268.65
52.98
1,678.88
41.18
94.55
55.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
862.51
750.41
680.15
540.19
621.48
651.52
704.97
80.62
63.02
52.28
ROA
2.46%
2.35%
10.59%
-2.01%
-1.02%
0.64%
118.37%
12.22%
9.84%
13.09%
ROE
7.78%
5.76%
25.55%
-4.96%
-1.98%
1.00%
190.57%
32.10%
26.46%
31.31%
ROCE
9.00%
7.19%
18.70%
3.30%
2.41%
2.60%
213.86%
24.26%
24.15%
26.00%
Fixed Asset Turnover
0.93
0.77
0.62
0.62
0.76
0.99
0.72
1.37
1.54
1.78
Receivable days
44.38
51.55
54.96
53.08
53.19
67.98
88.00
45.82
51.38
50.61
Inventory Days
30.89
40.00
47.02
48.12
51.81
71.06
92.29
47.24
48.86
52.50
Payable days
59.81
53.66
46.87
53.98
57.39
67.88
92.24
58.77
60.19
57.01
Cash Conversion Cycle
15.47
37.89
55.11
47.22
47.60
71.16
88.05
34.29
40.05
46.10
Total Debt/Equity
2.05
1.26
0.62
1.02
0.72
0.18
0.06
0.77
1.02
0.66
Interest Cover
1.64
1.78
6.94
0.59
0.66
1.56
187.46
3.72
2.72
5.30

News Update:


  • Piramal Enterprises - Quarterly Results
    6th Nov 2017, 12:00 AM

    Read More
  • Piramal Enterprises launches educational game for children
    23rd Oct 2017, 10:02 AM

    Developed at the Piramal Innovation Laboratory, Jungle Magic’s ‘Garden Sciencz’ provides a wide expanse of practical learning for children

    Read More
  • Piramal Enterprises to raise Rs 4,996.2 crore through bonds
    18th Oct 2017, 09:16 AM

    The administrative committee of the company’s board of directors has approved the issue of Confirmation of Allocation Note for allocation of 4,64,330 CCDs

    Read More
  • Piramal Enterprises planning to raise Rs 7,000 crore
    13th Oct 2017, 09:51 AM

    The company is planning to raise Rs 2,000 crore through a rights issue with an issue price of Rs 2,380 per equity share

    Read More
  • Piramal Enterprises’ PPS to expand its API manufacturing facilities
    11th Oct 2017, 10:02 AM

    The company will be making an investment of $55 million across its sites in North America and Asia

    Read More
  • Piramal Enterprises planning for amalgamation of wholly-owned subsidiaries
    10th Oct 2017, 11:23 AM

    The meeting of the Board of Directors of the Company will be held on October 12, 2017 to consider the same

    Read More
  • Piramal Enterprises’ arm to invest Rs 280 crore in ‘Puranik City Reserva’
    5th Oct 2017, 09:41 AM

    Puranik City Reserva is a unique theme-based ongoing project at Thane being developed on 13 acres of land with 2.2 million square feet development potential

    Read More
  • Piramal Enterprises’ arm enters into retail housing finance business
    28th Sep 2017, 11:19 AM

    The company will offer home loans as well as loans against property and construction finance for small developers

    Read More
  • Piramal Enterprises gets nod to raise funds up to Rs 600 crore
    18th Sep 2017, 09:58 AM

    The issue size is up to Rs 200 crore, and there is an option to retain over-subscription of Rs 400 crore

    Read More
  • Piramal Enterprises to raise funds up to Rs 200 crore
    16th Sep 2017, 10:55 AM

    The Meeting of Administrative Committee of the Board of Directors of the Company held on September 15, 2017 has approved the same

    Read More
  • Piramal Enterprises planning to raise funds up to Rs 400 crore
    14th Sep 2017, 09:39 AM

    The company has received approval for issue of secured NCDs up to Rs 250 crore with an option to retain over-subscription of up to Rs 150 crore

    Read More
  • Piramal Enterprises planning to raise funds up to Rs 600 crore
    13th Sep 2017, 09:56 AM

    The issue size is up to Rs 200 crore, there is an option to retain over-subscription of Rs 400 crore

    Read More
  • Piramal Enterprises’ arm receives Certificate of Registration as HFC
    4th Sep 2017, 16:24 PM

    Piramal Housing Finance made an application to the NHB for obtaining registration to commence Housing Finance Business

    Read More
  • Piramal Enterprises’ arm extends loans worth Rs 1,000 crore to Rustomjee Group: Report
    21st Aug 2017, 09:31 AM

    The loans are in the form of construction finance as well as corporate funding for growth requirement at the group level

    Read More
  • Piramal Enterprises’ arm acquires 100% stake in Context Matters
    17th Aug 2017, 09:05 AM

    Context Matters will provide DRG a core data asset for its Global Market Access data & analytics business

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.